Device Trial Radar · NCT07035925
Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas
Last checked: Nov 20, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Nov 24, 2025
Primary completion
Feb 24, 2027
Study completion Apr 24, 2028
Sponsor
- Lead sponsor
- ECM Therapeutics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 25, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety and Efficacy of ECMT-100 for the Treatment of Anorectal Fistulas
Conditions
- Fistula in Ano
Interventions
ECMT-100Device
Colloidal hydrogel
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventsTime frame: 12 months from treatment
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire · Recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.